Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease. Buffone E, Gupta S, Al Ibrahim B, Marshall JK, et al. J Clin Gastroenterol 2021 Nov 10. pii: 00004836-900000000-97351.

Read + Share

Amedeo Smart

Independent Medical Education

Buffone E, Gupta S, Al Ibrahim B, Marshall JK, et al. Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol 2021 Nov 10. pii: 00004836-900000000-97351.
PMID: 34753872